MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
-32.15%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$293M
AUM Growth
+$293M
(-37%)
Cap. Flow
-$4.72M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
iTeos Therapeutics
ITOS
|
$4.72M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iTeos Therapeutics
ITOS
| $88.1M | 30.12% | 2,738,785 -146,685 | -5% | -$4.72M |
|
2
Dyne Therapeutics
DYN
$1.92B
| $47.7M | 16.31% | 4,951,303 | – | – |
|
3
Entrada Therapeutics
TRDA
$208M
| $41.6M | 14.2% | 4,425,784 | – | – |
|
4
Repare Therapeutics
RPTX
$71.7M
| $31.9M | 10.92% | 2,242,636 | – | – |
|
|
AMYT
5
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $22.1M | 7.54% | 2,668,843 | – | – |
|
6
Werewolf Therapeutics
HOWL
$59.9M
| $18.9M | 6.44% | 4,284,172 | – | – |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $15.6M | 5.32% | 3,131,388 | – | – |
|
|
TCRR
8
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $11.2M | 3.82% | 4,050,865 | – | – |
|
9
Rhythm Pharmaceuticals
RYTM
$6.85B
| $10.5M | 3.58% | 909,258 | – | – |
|
|
ONCR
10
DELISTED
Oncorus, Inc.
ONCR
| $5.07M | 1.73% | 2,849,464 | – | – |
|